secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001022079-22-000150
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jim Davis becomes CEO and President of Quest Diagnostics; Rusckowski remains Chairman through March 2023
--------------------------------------------------------------------------------

- James E. Davis succeeds Steve Rusckowski as CEO and President effective November 1, 2022.
- Board expanded from 9 to 10 directors; Davis elected to fill the vacancy.
- Rusckowski, CEO since 2012, stays as Chairman until March 2023.
- Transition was first announced on February 3, 2022.
- Davis previously led Quest's COVID-19 operational response and held senior roles at GE and InSightec.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000150/0001022079-22-000150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207922000150/dgx-20221031.htm
  HTML page:      https://secwatch.observer/filing/0001022079-22-000150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer